Clinical Trials Browser

OTHER × Human Papillomavirus Recombinant Vaccine nonavalent × Gastrointestinal × Clear all

NCT03051516 2024-02-28

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Phase 4 Terminated

188 enrolled 13 charts

GastrointestinalGynecologic

High Grade Anal Canal Intraepithelial Neoplasia